Activist 13D/13G Filings - Lipocine Inc. (LPCN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-02-10
08:22 am
Purchase
13GLIPOCINE INC INC
LPCN
VANGUARD GROUP INC3,809,970
4.320%
218,966increase
(+6.10%)
View
2021-02-10
7:00 pm
Sale
13GLIPOCINE INC INC
LPCN
RENAISSANCE TECHNOLOGIES LLC0
0.000%
-1,901,256decrease
(Position Closed)
View
2021-02-10
2:41 pm
Sale
13GLIPOCINE INC INC
LPCN
Hudson Bay Capital Management LP0
0.000%
-3,932,593decrease
(Position Closed)
View
2021-02-10
11:14 am
Purchase
13GLIPOCINE INC INC
LPCN
VANGUARD GROUP INC3,591,004
5.470%
3,591,004increase
(New Position)
View
2021-01-05
09:20 am
Sale
13GLIPOCINE INC INC
LPCN
SABBY MANAGEMENT LLC0
0.000%
-3,361,344decrease
(Position Closed)
View
2020-02-25
12:39 pm
Purchase
13GLIPOCINE INC INC
LPCN
SABBY MANAGEMENT LLC3,361,344
11.000%
1,591,003increase
(+89.87%)
View
2020-02-12
2:27 pm
Purchase
13GLIPOCINE INC INC
LPCN
RENAISSANCE TECHNOLOGIES LLC1,901,256
5.360%
1,901,256increase
(New Position)
View
2020-02-06
3:27 pm
Purchase
13GLIPOCINE INC INC
LPCN
Hudson Bay Capital Management LP3,932,593
9.990%
3,932,593increase
(New Position)
View
2020-01-14
5:16 pm
Sale
13GLIPOCINE INC INC
LPCN
SABBY MANAGEMENT LLC1,770,341
11.000%
-1,329,659decrease
(-42.89%)
View